Resistance Testing for Integrase Strand Transfer Inhibitors in Naive, Human Immunodeficiency Virus–infected Individuals
Authors:
- 6 December 2018
- journal article
- letter
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 68 (11) , 1976-1977
Abstract
Juan Ambrosioni, Mar Mosquera, José M Miró; Resistance testing for integrase-strand-transfer inhibitors in naïve HIV infected individuals, Clinical InfectiousKeywords
This publication has 8 references indexed in Scilit:
- Antiretroviral Drugs for Treatment and Prevention of HIV Infection in AdultsJAMA, 2018
- Resistance to HIV Integrase Inhibitors: About R263K and E157Q MutationsViruses, 2018
- Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimenJournal of Antimicrobial Chemotherapy, 2018
- Should We Be Testing for Baseline Integrase Resistance in Patients Newly Diagnosed With Human Immunodeficiency Virus?Clinical Infectious Diseases, 2017
- Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infectionJournal of Antimicrobial Chemotherapy, 2016
- Prevalence of integrase inhibitor resistance mutations in Austrian patients recently diagnosed with HIV from 2008 to 2013Infection, 2016
- Recent trends and patterns in HIV‐1 transmitted drug resistance in the United KingdomHIV Medicine, 2016
- Primary resistance to integrase strand-transfer inhibitors in Europe: Table 1.Journal of Antimicrobial Chemotherapy, 2015